The death and life of the resurrection drug.
作者信息
Ebikeme Charles
机构信息
Science Writer, Paris, France.
出版信息
PLoS Negl Trop Dis. 2014 Jul 10;8(7):e2910. doi: 10.1371/journal.pntd.0002910. eCollection 2014 Jul.
Abstract
摘要
相似文献
1
The death and life of the resurrection drug.复活药的生死
PLoS Negl Trop Dis. 2014 Jul 10;8(7):e2910. doi: 10.1371/journal.pntd.0002910. eCollection 2014 Jul.
2
Saving for a rainy day: Control of energy needs in resurrection plants.未雨绸缪：复苏植物中能量需求的控制。
Plant Sci. 2018 Jun;271:62-66. doi: 10.1016/j.plantsci.2018.03.009. Epub 2018 Mar 14.
3
Death, resurrection, and rebirth: observations in cardiac surgery.
Psychoanal Q. 1983 Jan;52(1):56-72.
4
Immortality versus resurrection in the Christian tradition.基督教传统中的永生与复活。
Ann N Y Acad Sci. 2011 Oct;1234:76-82. doi: 10.1111/j.1749-6632.2011.06132.x.
5
Response of photosynthesis and respiration of resurrection plants to desiccation and rehydration.复苏植物光合作用和呼吸作用对干燥和复水的响应。
Planta. 1989 Feb;177(2):217-27. doi: 10.1007/BF00392810.
6
Resurrection plants optimize photosynthesis despite very thick cell walls by means of chloroplast distribution.复苏植物通过叶绿体分布优化光合作用，尽管细胞壁非常厚。
J Exp Bot. 2021 Mar 29;72(7):2600-2610. doi: 10.1093/jxb/erab022.
7
Sugar ratios, glutathione redox status and phenols in the resurrection species Haberlea rhodopensis and the closely related non-resurrection species Chirita eberhardtii.糖比、谷胱甘肽氧化还原状态和酚类物质在复苏物种 Haberlea rhodopensis 和密切相关的非复苏物种 Chirita eberhardtii 中的分布。
Plant Biol (Stuttg). 2011 Sep;13(5):767-76. doi: 10.1111/j.1438-8677.2010.00436.x. Epub 2011 Feb 15.
8
[Study on resurrection callus culture extract on the expression and mechanism of AQP-1 in Schwann cells after injury of the resurrection].[复活愈伤组织培养提取物对复活损伤后雪旺细胞中AQP-1表达及机制的研究]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Apr 5;31(7):529-533. doi: 10.13201/j.issn.1001-1781.2017.07.009.
9
Surviving metabolic arrest: photosynthesis during desiccation and rehydration in resurrection plants.在代谢停滞中存活：复苏植物脱水和复水过程中的光合作用
Ann N Y Acad Sci. 2016 Feb;1365(1):89-99. doi: 10.1111/nyas.12884. Epub 2015 Sep 16.
10
Arabinose-rich polymers as an evolutionary strategy to plasticize resurrection plant cell walls against desiccation.富含阿拉伯糖的聚合物作为一种进化策略，可使复苏植物细胞壁在脱水时具有塑性。
Planta. 2013 Mar;237(3):739-54. doi: 10.1007/s00425-012-1785-9. Epub 2012 Nov 2.
引用本文的文献
1
Polyamine Metabolism in Parasites: A Promising Therapeutic Target.寄生虫中的多胺代谢：有前途的治疗靶点。
Med Sci (Basel). 2022 Apr 22;10(2):24. doi: 10.3390/medsci10020024.
2
The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.昏睡病的药物：其作用机制、耐药性及简史
Trop Med Infect Dis. 2020 Jan 19;5(1):14. doi: 10.3390/tropicalmed5010014.
3
Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases.α-二氟甲基鸟氨酸，一种多胺生物合成的不可逆抑制剂，作为治疗过度增殖性疾病和感染性疾病的策略。
Med Sci (Basel). 2018 Feb 8;6(1):12. doi: 10.3390/medsci6010012.
4
Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.针对寄生原生动物的治疗药物设计中的三维结构：对过去、现在和未来的思考
Acta Crystallogr F Struct Biol Commun. 2015 May;71(Pt 5):485-99. doi: 10.1107/S2053230X15004987. Epub 2015 Apr 16.
本文引用的文献
1
Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.非洲锥虫病的耐药性：美拉胂醇和喷他脒的故事。
Trends Parasitol. 2013 Mar;29(3):110-8. doi: 10.1016/j.pt.2012.12.005. Epub 2013 Jan 30.
2
In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.硝呋替莫-依氟鸟氨酸联合疗法（NECT）治疗冈比亚锥虫病的院内现场条件下的安全性。
PLoS Negl Trop Dis. 2012;6(11):e1920. doi: 10.1371/journal.pntd.0001920. Epub 2012 Nov 29.
3
Management of trypanosomiasis and leishmaniasis.锥虫病和利什曼病的治疗。
Br Med Bull. 2012;104(1):175-96. doi: 10.1093/bmb/lds031. Epub 2012 Nov 7.
4
Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.硝呋替莫-依氟鸟氨酸联合疗法治疗第二阶段冈比亚锥虫病：无国界医生组织在刚果民主共和国的经验。
Clin Infect Dis. 2013 Jan;56(2):195-203. doi: 10.1093/cid/cis886. Epub 2012 Oct 16.
5
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.更新现有的抗人体非洲锥虫病化疗药物的现场使用情况。
Parasitology. 2012 Jun;139(7):842-6. doi: 10.1017/S0031182012000169. Epub 2012 Feb 6.
6
Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.在暴力冲突地区控制昏睡病的挑战：刚果民主共和国的经验。
Confl Health. 2011 May 26;5:7. doi: 10.1186/1752-1505-5-7.
7
The development of drugs for treatment of sleeping sickness: a historical review.治疗昏睡病药物的研发：历史回顾
Parasit Vectors. 2010 Mar 10;3(1):15. doi: 10.1186/1756-3305-3-15.
8
Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.硝呋替莫-依氟鸟氨酸联合疗法治疗布氏冈比亚锥虫二期昏睡病：刚果的一项随机临床试验
Clin Infect Dis. 2007 Dec 1;45(11):1435-42. doi: 10.1086/522982. Epub 2007 Oct 22.
9
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.美拉胂醇与依氟鸟氨酸治疗刚果共和国晚期冈比亚锥虫病的疗效比较
Bull World Health Organ. 2006 Oct;84(10):783-91. doi: 10.2471/blt.06.031955.
10
Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.依氟鸟氨酸在治疗第二阶段布氏冈比亚锥虫人类非洲锥虫病方面比美拉胂醇更安全。
Clin Infect Dis. 2005 Sep 1;41(5):748-51. doi: 10.1086/432576. Epub 2005 Jul 19.
Zotero 插件